Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AWH | Common Stock | Options Exercise | $0 | +8.44K | +17.31% | $0.00 | 57.2K | Sep 30, 2024 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AWH | Restricted Stock Units | Options Exercise | $0 | -8.44K | -25% | $0.00 | 25.3K | Sep 30, 2024 | Common Stock | 8.44K | Direct | F2, F3 |
Id | Content |
---|---|
F1 | Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,438 of which vested on September 30, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024. |
F2 | Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock. |
F3 | On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,438 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4. |